OneSpaWorld Hldgs 株価情報 (NASDAQ: OSW)

最新ニュース OneSpaWorld Hldgs (NASDAQ:OSW) 株価情報

OneSpaWorld Hldgs

OneSpaWorld Holdings

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

OneSpaWorld Holdings Limited - Common Shares

OneSpaWorld Holdings Ltd

OneSpaWorld Holdings Ltd Warrants (19/03/2024)

On Wednesday, Denali Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) provided an update on Regimen G of the Phase 2/3 HEALEY ALS Platform Trial of DNL343 for <a target="_blank" href="https://www.benzinga.com/general/biotech" rel="noreferrer noopener">amyotrophic lateral sclerosis</a>.
The company said that further analyses did not demonstrate a treatment effect on neurofilament light (NfL), a biomarker of neuronal damage, over the 24-week, double-blind period and in a subset of participants that completed an additional 28 weeks in the open-label active treatment extension.
The company plans to discontinue the active treatment extension in Regimen, according to an SEC <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1714899/000171489925000072/dnli-20250305.htm" target="_blank" rel="noreferrer noopener">filing</a>. Overall, DNL343 was found to be safe and well-tolerated.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/42856965/denali-therapeutics-amyotrophic-lateral-sclerosis-misses-pivotal-trial-but-analyst-says-it-was-expected" rel="noreferrer noopener">Denali Therapeutics&#8217; Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected</a>
Data from Regimen G will be presented at a future medical meeting. Denali intends to assess potential future development opportunities for DNL343.
In January, Denali revealed topline results from an analysis of Regimen G of the Phase 2/3 HEALEY ALS Platform Trial evaluating DNL343 for amyotrophic lateral sclerosis.
Compared to placebo, the study did not meet the primary endpoint of efficacy in <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/42856965/denali-therapeutics-amyotrophic-lateral-sclerosis-misses-pivotal-trial-but-analyst-says-it-was-expected" rel="noreferrer noopener">slowing disease progression</a>.
William Blair analysts found the update &#8220;disappointing,&#8221; but largely expected following the previous update on the failed study. The analyst sees little impact on fair value estimates, which have been slightly lowered from $32/share to $30/share.
Analyst Sarah Schram believes the key investment focus will be on 2025 updates regarding the FDA&#8217;s accelerated approval application for Tividenofusp alfa in Hunter syndrome, with potential approval by late 2025 or early 2026.
Schram also expects clarity on the regulatory process for DNL126 in Sanfilippo syndrome, likely following a similar path as Tividenofusp.
Additionally, the company plans to expand its transport vehicle platform, aiming to move one or two new treatments into clinical trials each year for the next three years.
Based on biomarker and clinical data, Schram sees Tividenofusp as a leading treatment for Hunter syndrome. She believes the market is undervaluing the drug and the company's platform. This could also be used for common diseases like Parkinson's and Alzheimer's.
William Blair reiterates the Outperform rating on Denali and remains a buyer on the recent weakness.
Price Action: Denali stock is down 2.64% at $15.87 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44169392/kroger-beats-q4-earnings-estimates-amid-leadership-shakeup" target="_blank" rel="noreferrer noopener">Kroger Q4 Earnings: EPS Beat, Sales Miss, Soft Outlook And More</a></li>
</ul>

Analyst Color

Biotech

News

Health Care

Analyst Ratings

General

DNLI

Denali Therapeutics Ends ALS Trial Extension, Analyst Stays Optimistic Despite Trial Setback

WIIM

SBUX

Starbucks shares are trading lower following a report suggesting the company needed to reorganize to make leaders more accountable for financial and operational improvements. The stock may also be falling amid a drop in coffee production.

Morgan Stanley analyst Shannon O'Callaghan maintains Guardant Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) with a Overweight and raises the price target from $42 to $52.

Price Target

Morgan Stanley Maintains Overweight on Guardant Health, Raises Price Target to $52

PINS

Pinterest CEO Bill Ready Says About 15% Of Our Code Base Is Now Generated Through AI

Morgan Stanley analyst Erik Woodring maintains Cricut (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) with a Underweight and lowers the price target from $3.9 to $3.8.

CRCT

Morgan Stanley Maintains Underweight on Cricut, Lowers Price Target to $3.8

GEVO

Gevo Announces That It Will Delay The Issuance Of Its Q4 And FY24 Earnings Release And Investor Conference Call Previously Scheduled for March 6, 2025

Atlantic International Corp. ("Atlantic") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATLN#NASDAQ">ATLN</a>), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions ("Lyneer") has secured a significant contract renewal with a premier North American baking company in Northern California.
The renewed partnership includes an expansion to additional locations, positioning Lyneer to capture approximately $10 million in spending. This expanded relationship underscores Lyneer's proven track record of delivering high-quality workforce solutions tailored to the specialized needs of the food production industry.

Contracts

ATLN

Atlantic International Corp Announces Its Subsidiary Lyneer Staffing Solutions Has Secured A Contract Renewal With A Premier North American Baking Company In Northern California

Investors with a lot of money to spend have taken a bearish stance on Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ORCL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 39 uncommon options trades for Oracle.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 51%, bearish.
Out of all of the special options we uncovered, 21 are puts, for a total amount of $2,070,633, and 18 are calls, for a total amount of $938,791.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $95.0 to $180.0 for Oracle during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Oracle's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Oracle's significant trades, within a strike price range of $95.0 to $180.0, over the past month.
<h3>Oracle Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741280492_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.85</td>
<td>$10.65</td>
<td>$10.9</td>
<td>$135.00</td>
<td>$545.0K</td>
<td>420</td>
<td align="right">500</td>
</tr>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$21.7</td>
<td>$21.25</td>
<td>$21.75</td>
<td>$170.00</td>
<td>$326.2K</td>
<td>3.0K</td>
<td align="right">150</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.0</td>
<td>$13.85</td>
<td>$13.85</td>
<td>$160.00</td>
<td>$138.5K</td>
<td>1.7K</td>
<td align="right">3</td>
</tr>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$6.5</td>
<td>$6.25</td>
<td>$6.5</td>
<td>$162.50</td>
<td>$125.4K</td>
<td>1.0K</td>
<td align="right">211</td>
</tr>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.88</td>
<td>$1.85</td>
<td>$1.88</td>
<td>$135.00</td>
<td>$112.4K</td>
<td>14.7K</td>
<td align="right">608</td>
</tr>
</tbody>
</table>

<h3>About Oracle</h3>
Oracle provides enterprise applications and infrastructure offerings around the world through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used for running online transaction processing and data warehousing workloads. Besides database systems, Oracle also sells enterprise resource planning, or ERP, customer relationship management, or CRM, and human capital management, or HCM, applications. Today, Oracle has more than 159,000 full-time employees in over 170 countries.
<h3>Current Position of Oracle</h3>
<ul>
<li>With a trading volume of 3,908,152, the price of ORCL is down by -4.12%, reaching $154.91.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 4 days from now.</li>
</ul>
<h3>What The Experts Say On Oracle</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $220.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Guggenheim downgraded its rating to Buy, setting a price target of $220. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Oracle with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

ORCL

What the Options Market Tells Us About Oracle

Victorias Secret &amp; Co.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) shares are trading lower on Thursday after the company issued first-quarter and FY25 sales <a target="_blank" href="https://www.benzinga.com/news/earnings/25/03/44165610/victorias-secret-delivers-solid-q4-results-but-ceo-warns-of-near-term-headwinds" rel="noreferrer noopener">guidance below estimates.</a>
Revenue rose&nbsp;1%&nbsp;year over year to&nbsp;$2.11&nbsp;billion, beating the consensus of&nbsp;$2.09 billion, and adjusted EPS&nbsp;of&nbsp;$2.60 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat&nbsp;the consensus of&nbsp;$2.30</a>.
The company expects&nbsp;net sales of&nbsp;$1.30 billion – $1.33 billion vs. consensus of $1.39 billion&nbsp;for the&nbsp;first quarter and $6.2 billion – $6.3 billion&nbsp;vs. <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus of $6.34 billion for FY25</a>.
J.P. Morgan analyst Matthew R. Boss lowered the price forecast from $43.00 to<a target="_blank" href="https://www.benzinga.com/quote/VSCO/analyst-ratings" rel="noreferrer noopener"> $35.00, with a Neutral rating</a>.
The analyst writes that for the balance of the year, management&#8217;s full-year guidance implies that the second quarter-fourth quarter revenues will accelerate to +1% growth on average (&gt; first quarter&#8217;s -4% to -2% guidance range).
Boss notes that second quarter-fourth quarter same-store-sales comparisons on a 1-year basis are sequentially harder versus first quarter by 670bps.
The analyst writes that after recent leadership changes in the C-Suite and merchandising/product functions, VSCO is starting to see topline growth across both the VS and PINK brands.
Although the turnaround is still in the early stages, there is a multi-year opportunity to drive higher full-price selling, expand gross margins, and leverage SG&amp;A on sustained revenue growth, ultimately improving operating margins, says the analyst.
The analyst cut the FY25 EPS estimates to $2.30 from $2.74 (vs. Street $2.80) and expects FY26 EPS of $2.40 (vs. Street $3.14).
Other analyst&#8217;s price forecast revisions include:
<ul>
<li>Wells Fargo analyst Ike Boruchow cut the price forecast from $40 to $25, while keeping an Equal-Weight rating.</li>
<li>BMO Capital analyst Simeon Siegel reiterated an Outperform rating and lowered the price forecast from $46 to $31.</li>
<li>Telsey Advisory Group analyst Dana Telsey kept a Market Perform rating and slashed the price forecast from $40 to $24.</li>
</ul>
Price Action: VSCO shares are down 2.96% at $21.55 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44146094/wall-street-awaits-trumps-tariff-decision-digests-mixed-economic-data-whats-driving-markets-wednesday" target="_blank" rel="noreferrer noopener">Wall Street Awaits Trump&#8217;s Tariff Decision, Digests Mixed Economic Data: What&#8217;s Driving Markets Wednesday?</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

Reiteration

Trading Ideas

VSCO

Victoria's Secret Turnaround In Progress But Challenges Remain: Analyst Lowers Forecast

Investors with a lot of money to spend have taken a bearish stance on Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ADBE, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 29 uncommon options trades for Adobe.
This isn't normal.
The overall sentiment of these big-money traders is split between 34% bullish and 55%, bearish.
Out of all of the special options we uncovered, 14 are puts, for a total amount of $788,618, and 15 are calls, for a total amount of $684,345.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $560.0 for Adobe, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Adobe's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Adobe's substantial trades, within a strike price spectrum from $220.0 to $560.0 over the preceding 30 days.
<h3>Adobe 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741280487_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$10.05</td>
<td>$9.75</td>
<td>$9.93</td>
<td>$420.00</td>
<td>$148.9K</td>
<td>4.1K</td>
<td align="right">150</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$250.5</td>
<td>$247.75</td>
<td>$250.5</td>
<td>$220.00</td>
<td>$125.2K</td>
<td>15</td>
<td align="right">0</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/04/25</td>
<td>$20.15</td>
<td>$18.8</td>
<td>$20.15</td>
<td>$450.00</td>
<td>$100.7K</td>
<td>73</td>
<td align="right">0</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$51.0</td>
<td>$50.9</td>
<td>$51.0</td>
<td>$475.00</td>
<td>$76.5K</td>
<td>58</td>
<td align="right">0</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$48.3</td>
<td>$47.8</td>
<td>$48.3</td>
<td>$490.00</td>
<td>$72.4K</td>
<td>39</td>
<td align="right">15</td>
</tr>
</tbody>
</table>

<h3>About Adobe</h3>
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
Having examined the options trading patterns of Adobe, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Adobe</h3>
<ul>
<li>Currently trading with a volume of 674,542, the ADBE's price is down by -0.46%, now at $449.18. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 6 days.</li>
</ul>
<h3>Expert Opinions on Adobe</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $552.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from BMO Capital continues to hold a Outperform rating for Adobe, targeting a price of $515. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $590. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Adobe, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

ADBE

Market Whales and Their Recent Bets on ADBE Options

Whales with a lot of money to spend have taken a noticeably bearish stance on Philip Morris Intl.
Looking at options history for Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $238,106 and 5, calls, for a total amount of $336,708.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $85.0 to $170.0 for Philip Morris Intl during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Philip Morris Intl options trades today is 1068.0 with a total volume of 324.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Philip Morris Intl's big money trades within a strike price range of $85.0 to $170.0 over the last 30 days.
<h3>Philip Morris Intl 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741280482_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$7.8</td>
<td>$7.7</td>
<td>$7.8</td>
<td>$160.00</td>
<td>$125.5K</td>
<td>3.4K</td>
<td align="right">3</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$68.9</td>
<td>$68.2</td>
<td>$68.54</td>
<td>$85.00</td>
<td>$54.8K</td>
<td>8</td>
<td align="right">40</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$68.9</td>
<td>$67.8</td>
<td>$68.37</td>
<td>$85.00</td>
<td>$54.6K</td>
<td>8</td>
<td align="right">16</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$18.3</td>
<td>$18.0</td>
<td>$18.21</td>
<td>$170.00</td>
<td>$50.9K</td>
<td>191</td>
<td align="right">56</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$63.9</td>
<td>$63.2</td>
<td>$63.55</td>
<td>$90.00</td>
<td>$50.8K</td>
<td>8</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Philip Morris Intl</h3>
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.
After a thorough review of the options trading surrounding Philip Morris Intl, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Philip Morris Intl</h3>
<ul>
<li>Currently trading with a volume of 1,434,830, the PM's price is up by 0.01%, now at $153.16. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
<h3>What The Experts Say On Philip Morris Intl</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $153.75.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Stifel persists with their Buy rating on Philip Morris Intl, maintaining a target price of $160. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Philip Morris Intl, targeting a price of $175. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Sell rating on Philip Morris Intl with a target price of $120. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Philip Morris Intl, targeting a price of $160. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Philip Morris Intl options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Smart Money Is Betting Big In Philip Morris Intl Options

Kevin O&#8217;Leary has a sharp message for consumers drowning in credit card debt: take a hard look at your closet. According to the <a href="https://www.benzinga.com/startups/24/09/40839130/were-looking-for-a-real-a-e-and-youre-in-kevin-oleary-on-how-he-got-his-infamous-shark-tank-role">&#8220;Shark Tank&#8221; investor</a>, most people only wear about 25% of what they own, while the other 75% is just &#8220;dead money.&#8221;
<h2 class="wp-block-heading">The Cost of Unworn Clothes</h2>
&#8220;One of the reasons I&#8217;m an investor in almost all the credit card companies is they make a lot of money on a predatory basis,&#8221; O&#8217;Leary said in a recent <a href="https://x.com/kevinolearytv/status/1896225233457005037">video</a>. &#8220;They get you to spend on things you don&#8217;t need. Go into your closet and look at your shoes, your jeans, your T-shirts, and your suits. Just there. Everybody has those, men or women. You&#8217;re only wearing 25% of them.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Credit card companies love getting you to buy things you don't need. Go check your closet—you're only wearing 25% of what's in there. That other 75%? Dead money. If you'd invested that cash instead, you'd be sitting on millions at retirement. But hey, enjoy those sneakers. <a href="https://t.co/6w6wNg8Rd3">pic.twitter.com/6w6wNg8Rd3</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1896225233457005037?ref_src=twsrc%5Etfw">March 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">Here's how to know if your nest egg is keeping pace.</a></li>
</ul>
Instead of letting money sit in unworn clothing, O&#8217;Leary argues that investing even a fraction of that cash could make a <a href="https://www.benzinga.com/news/25/03/44081583/my-mom-was-not-a-stock-analyst-just-a-working-woman-when-she-passed-she-was-rich-kevin-oleary-reveals-her-lifelong-process-you-can-copy">huge difference in the long run</a>. &#8220;That money is dead. It could have made eight percent a year. And you do that for 60 years, you have nothing to speak of,&#8221; he warned.
<h2 class="wp-block-heading">Americans Are Drowning in Credit Card Debt</h2>
O&#8217;Leary&#8217;s concerns come at a time when credit card debt in the U.S. has hit an all-time high. By the end of the fourth quarter of 2024, <a href="https://www.benzinga.com/news/25/02/43888952/americans-owe-a-record-1-21-trillion-in-credit-card-debt-expert-warns-theres-no-end-in-sight">Americans owed a record $1.21 trillion</a> on their credit cards, up $45 billion from the previous quarter. Holiday spending played a major role, with consumers shelling out $702 billion during the season, <a href="https://fred.stlouisfed.org/series/RSXFSN">according to the Federal Reserve Bank of St. Louis</a>.
Trending: Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.
At the same time, more Americans are falling behind on their payments. Over 10.9% of credit card accounts were more than 90 days delinquent in the third quarter of 2024, the highest rate since 2012. LendingTree Chief Credit Analyst Matt Schulz <a href="https://www.nbcnews.com/business/personal-finance/credit-card-debt-hit-record-1point21-trillion-no-one-surprised-rcna192128">explained</a> the reason behind the rising debt: &#8220;Stubborn inflation has shrunk a lot of Americans&#8217; financial margin for error from slim to about none, forcing people to lean more heavily on credit card debt.&#8221;
Adding to the strain, the average credit card interest rate has climbed above 20%, making it even harder for those carrying a balance to pay off their debt.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
<h2 class="wp-block-heading">O&#8217;Leary's Simple Investment Strategy</h2>
O&#8217;Leary believes the cycle of overspending and accumulating debt is setting people up for financial failure. Instead, he suggests a simple alternative: &#8220;If all you did was take 15% of your salary and put it into, you know, a very simple portfolio, just buy the index, the S&amp;P, you&#8217;d have a million and a half dollars when you retire.&#8221;
With the average American salary at $69,000, setting aside 15%—or about $10,350 per year—into an S&amp;P 500 index fund could <a href="https://www.benzinga.com/money/smartasset">build substantial wealth over time</a>.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
</ul>

Kevin O'Leary Says Your Closet Is Full Of 'Dead Money'—Invest Instead, And You Could Retire With Millions

<a href="https://www.wsj.com/business/hospitality/starbucks-ceo-tells-workers-to-step-it-up-after-layoffs-3fdba9f3" title="https://www.wsj.com/business/hospitality/starbucks-ceo-tells-workers-to-step-it-up-after-layoffs-3fdba9f3">https://www.wsj.com/business/hospitality/starbucks-ceo-tells-workers-to-step-it-up-after-layoffs-3fdba9f3</a>

Management

Reported March 5, 2025: "Starbucks CEO Tells Workers To Step It Up After Layoffs; Brian Niccol Says Coffee Chain's Turnaround Hinges On Greater Accountability; 'We Own Whether Or Not This Place Grows'" - WSJ

Macro Economic Events

Global

Economics

Mexico President Claudia Sheinbaum Says Agreement To Pause Tariffs On Mexico's USMCA-Compliant Goods Is Until April 2; We Will Also Work Together On Crossing Of Guns Into Mexico

Mexico President Claudia Sheinbaum Says Call With Trump Was 'Excellent And Respectful'; We Will Keep Working Together Particularly On Migration And Security, Particularly Crossing Of Fentanyl Into U.S.

Hemostemix Inc.&nbsp;(TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HEM#TSXV">HEM</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/HMTXF#OTCQB">HMTXF</a>) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>) ("Firefly"), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders.
Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the "Phase 1").
Hemostemix's Phase 1 clinical trial of vascular dementia is in line with Firefly's collaborations with globally recognized companies, such as <a href="https://api.newsfilecorp.com/redirect/zEOgMSVq8m">Bright Minds</a>, <a href="https://api.newsfilecorp.com/redirect/4QpovibV0V">Novartis</a> and <a href="https://api.newsfilecorp.com/redirect/jpDzBSo5qM">Takeda.</a> Through the collaboration, Hemostemix will leverage Firefly's proprietary database of 77,000 EEG brain scans across twelve disorders. Hemostemix and FireFly will work together to generate an exploratory endpoint to objectively prove that intrathecal injection of ACP-01 is a safe, preliminarily efficacious, and clinically relevant treatment for vascular dementia.

AIFF

HMTXF

TSXV:HEM

Hemostemix And FireFly Neuroscience's Brain Network Analytics Engage To Complete Phase 1 Vascular Dementia Clinical Trial Of ACP-01

Retailers are facing selling pressure this week following warnings about continued consumer uncertainty and the potential <a href="https://www.benzinga.com/25/03/44140954/tariffs-cast-a-shadow-over-best-buy-target-but-is-it-a-buying-opportunity">impacts of tariffs</a>.
What To Know: Trade war fears are rising after President Donald Trump imposed 25% tariffs on imports from Canada and Mexico earlier this week. Trump also doubled tariffs on China from 10% to 20%, which has been met with retaliatory tariffs on American goods.
Consumer confidence has also soured in recent months as some GDP forecasts have turned negative and consumer spending&nbsp;unexpectedly <a href="https://www.benzinga.com/news/econ-s/25/02/43736972/us-retail-sales-fall-more-than-expected-raise-growth-concerns" target="_blank" rel="noreferrer noopener">declined in January</a>. Inflation also remains top of mind with&nbsp;<a href="https://www.benzinga.com/news/25/02/43667632/inflation-rises-in-january-housing-costs-up-adding-to-consumers-2025-concerns" target="_blank" rel="noreferrer noopener">Consumer Price Index&nbsp;data</a>&nbsp;from January showing a 3% rise, above economist forecasts.&nbsp;If inflation remains elevated above the Federal Reserve's 2% goal, rates are not likely to come down anytime soon.
Earnings from retailers this week have also weighed on consumer sentiment. Despite beating estimates on the top and bottom lines in the fourth quarter, Target Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) shares plunged after the retailer warned that February sales were weak and said it expects to see a &#8220;meaningful&#8221; decline in profits in the first quarter.
Target attributed &#8220;soft&#8221; February sales to declining consumer confidence paired with cold weather, per <a href="https://www.cnbc.com/2025/03/04/target-tgt-q4-2024-earnings.html">CNBC</a>. 
&#8220;Looking ahead, we expect to see a moderation in this trend as apparel sales respond to warmer weather around the country, and consumers turn to Target for upcoming seasonal moments such as the Easter holiday,&#8221; CFO Jim Lee said. &#8220;We will continue to monitor these trends and will remain appropriately cautious with our expectations for the year ahead.&#8221;
Target CEO Brian Cornell also told CNBC that Trump&#8217;s tariffs on Mexican imports that went into effect on Tuesday could end up causing Target and other grocers to increase prices on produce such as bananas, strawberries and avocados. 
Related Link: <a href="https://www.benzinga.com/25/03/44149833/trump-delays-ford-gm-stellantis-from-from-tariffs-on-mexico-canada-for-one-month">Trump Delays Ford, GM, Stellantis Tariffs On Mexico, Canada For One Month</a>
Best Buy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) also reported earnings this week that came in above analyst expectations, but shares traded down after CEO Corie Barry warned price increases are &#8220;highly likely&#8221; due to Trump&#8217;s tariffs, according to <a href="https://www.cnbc.com/2025/03/04/best-buy-bby-q4-2025-earnings.html">CNBC</a>.
Barry told investors and analysts on the earnings call that about 55% of Best Buy&#8217;s products are sourced from China and about 20% come from Mexico. 
&#8220;Trade is critically important to our business and industry. The consumer electronic supply chain is highly global, technical and complex. We expect our vendors across our entire assortment will pass along some level of tariff costs to retailers, making price increases for American consumers highly likely,&#8221; Barry said.
Although the company only directly imports about 2% to 3% of its products, Best Buy is reportedly making adjustments to its supply chain sourcing in response to tariffs. The company also expressed concerns about the consumer&#8217;s ability to keep spending in the face of price increases. 
"The giant wild card here, obviously, is how the consumers are going to react to the price increases, in light of a lot of price increases potentially throughout the year and a general consumer confidence that is showing little signs of weakness at the moment," Best Buy CFO Matt Bilunas reportedly said on the conference call following earnings.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/03/44164706/european-central-bank-cuts-interest-rates-marking-sixth-cut-in-9-months">European Central Bank Cuts Interest Rates Marking Sixth Cut In 9 Months</a></li>
</ul>
Photo: Shutterstock.

Government

Regulations

Retailers Warn Of Price Increases Due To Trump Tariffs As Consumer Health Concerns Persist

Pinterest CEO Bill Ready Says We Just Launched Item-Level And Return On Ad Spend Bidding Strategies; A Retailer Testing This Achieved Better Ad Performance And Captured Larger Share Of Customer Spending

Tonix Pharmaceuticals Holding Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares have surged 115% to $16.85 since Monday's open, driven by a series of key business updates this week.
What To Know: Tonix this week <a href="https://www.benzinga.com/pressreleases/25/03/g44104557/tonix-pharmaceuticals-presented-data-and-analyses-of-tnx-102-sl-treatment-effects-on-fibromyalgia-">announced data</a> regarding its fibromyalgia treatment, TNX-102 SL, presenting Phase 3 data at the 7th International Congress on Controversies in Fibromyalgia. 
The study showed that the sublingual formulation demonstrated a statistically significant improvement in the primary endpoint of reduction in fibromyalgia pain reduced pain. The U.S. FDA has set an August 15, 2025, Prescription Drug User Fee Act (PDUFA) goal date for potential marketing approval.
Tonix also announced the appointment of Siobhan Fogarty as Chief Technical Officer and <a href="https://www.benzinga.com/pressreleases/25/03/g44137620/tonix-pharmaceuticals-to-present-at-the-2025-virtual-investor-summit">confirmed</a> COO Jessica Morris will present at the 2025 Virtual Investor Summit on March 11.
Read Also: <a href="https://www.benzinga.com/news/global/25/03/44166916/whats-going-on-with-alibaba-stock-thursday-6">What&#8217;s Going On With Alibaba Stock Thursday?</a>
<h2 class="wp-block-heading">How To Buy TNXP Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Tonix Pharmaceuticals&#8217; case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, TNXP has a 52-week high of $1,216.00 and a 52-week low of $6.76.

TNXP

Tonix Pharmaceuticals (TNXP) Stock Is Up 115% This Week: What's Going On?

Financial giants have made a conspicuous bullish move on Burlington Stores. Our analysis of options history for Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) revealed 13 unusual trades.
Delving into the details, we found 38% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $122,670, and 11 were calls, valued at $637,840.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $230.0 to $300.0 for Burlington Stores during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Burlington Stores's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Burlington Stores's whale trades within a strike price range from $230.0 to $300.0 in the last 30 days. 
<h3>Burlington Stores Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741279592_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BURL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$27.7</td>
<td>$26.9</td>
<td>$27.19</td>
<td>$240.00</td>
<td>$249.3K</td>
<td>2.0K</td>
<td align="right">527</td>
</tr>
<tr>
<td>BURL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.8</td>
<td>$8.0</td>
<td>$8.52</td>
<td>$267.50</td>
<td>$79.6K</td>
<td>0</td>
<td align="right">571</td>
</tr>
<tr>
<td>BURL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$8.9</td>
<td>$6.3</td>
<td>$7.3</td>
<td>$250.00</td>
<td>$72.6K</td>
<td>31</td>
<td align="right">119</td>
</tr>
<tr>
<td>BURL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$27.4</td>
<td>$26.8</td>
<td>$27.08</td>
<td>$240.00</td>
<td>$65.0K</td>
<td>2.0K</td>
<td align="right">230</td>
</tr>
<tr>
<td>BURL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$51.0</td>
<td>$50.0</td>
<td>$50.0</td>
<td>$300.00</td>
<td>$50.0K</td>
<td>0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Burlington Stores</h3>
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.
After a thorough review of the options trading surrounding Burlington Stores, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Burlington Stores</h3>
<ul>
<li>With a trading volume of 1,556,967, the price of BURL is up by 11.61%, reaching $264.46.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 0 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Burlington Stores</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $340.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Outperform rating on Burlington Stores with a target price of $340. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Burlington Stores, targeting a price of $340. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Burlington Stores options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

BURL

Decoding Burlington Stores's Options Activity: What's the Big Picture?

Press Releases

OneSpaWorld Announces Second Quarter Fiscal 2024 Financial Results on July 31, 2024

OneSpaWorld Reports Record Second Quarter Fiscal 2024 Results and Increases Fiscal Year Guidance

OneSpaWorld Publishes Inaugural Sustainability and Social Responsibility Report

OneSpaWorld Announces Third Quarter Fiscal 2024 Financial Results on October 30, 2024

OneSpaWorld Reports Record Third Quarter Fiscal 2024 Results and Increases Fiscal Year Guidance

OneSpaWorld Announces Participation in the ICR Conference 2025

OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2024 Revenue and Adjusted EBITDA Ahead of Guidance and Introduces Fiscal 2025 Revenue and Adjusted EBITDA Guidance

Comments

OneSpaWorld Hldgs

ニュース

最新ニュース OneSpaWorld Hldgs (NASDAQ:OSW) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル